Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2010 Mar 12;28511:8302-15. doi: 10.1074/jbc.M109.074161.
Show Gene links
Show Anatomy links
Structural and functional characterization of a novel homodimeric three-finger neurotoxin from the venom of Ophiophagus hannah (king cobra).
Roy A
,
Zhou X
,
Chong MZ
,
D'hoedt D
,
Foo CS
,
Rajagopalan N
,
Nirthanan S
,
Bertrand D
,
Sivaraman J
,
Kini RM
.
???displayArticle.abstract???
Snake venoms are a mixture of pharmacologically active proteins and polypeptides that have led to the development of molecular probes and therapeutic agents. Here, we describe the structural and functional characterization of a novel neurotoxin, haditoxin, from the venom of Ophiophagus hannah (King cobra). Haditoxin exhibited novel pharmacology with antagonism toward muscle (alphabetagammadelta) and neuronal (alpha(7), alpha(3)beta(2), and alpha(4)beta(2)) nicotinic acetylcholine receptors (nAChRs) with highest affinity for alpha(7)-nAChRs. The high resolution (1.5 A) crystal structure revealed haditoxin to be a homodimer, like kappa-neurotoxins, which target neuronal alpha(3)beta(2)- and alpha(4)beta(2)-nAChRs. Interestingly however, the monomeric subunits of haditoxin were composed of a three-finger protein fold typical of curaremimetic short-chain alpha-neurotoxins. Biochemical studies confirmed that it existed as a non-covalent dimer species in solution. Its structural similarity to short-chain alpha-neurotoxins and kappa-neurotoxins notwithstanding, haditoxin exhibited unique blockade of alpha(7)-nAChRs (IC(50) 180 nm), which is recognized by neither short-chain alpha-neurotoxins nor kappa-neurotoxins. This is the first report of a dimeric short-chain alpha-neurotoxin interacting with neuronal alpha(7)-nAChRs as well as the first homodimeric three-finger toxin to interact with muscle nAChRs.
Aird,
Primary structure of gamma-bungarotoxin, a new postsynaptic neurotoxin from venom of Bungarus multicinctus.
1999, Pubmed
Aird,
Primary structure of gamma-bungarotoxin, a new postsynaptic neurotoxin from venom of Bungarus multicinctus.
1999,
Pubmed
Antil,
Variability among the sites by which curaremimetic toxins bind to torpedo acetylcholine receptor, as revealed by identification of the functional residues of alpha-cobratoxin.
1999,
Pubmed
Antil-Delbeke,
Molecular determinants by which a long chain toxin from snake venom interacts with the neuronal alpha 7-nicotinic acetylcholine receptor.
2000,
Pubmed
Barlow,
Coevolution of diet and prey-specific venom activity supports the role of selection in snake venom evolution.
2009,
Pubmed
Berman,
The Protein Data Bank.
2000,
Pubmed
Bourne,
Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors.
2005,
Pubmed
Bülbring,
Observations on the isolated phrenic nerve diaphragm preparation of the rat. 1946.
1997,
Pubmed
Changeux,
Use of a snake venom toxin to characterize the cholinergic receptor protein.
1970,
Pubmed
Changeux,
The TiPS lecture. The nicotinic acetylcholine receptor: an allosteric protein prototype of ligand-gated ion channels.
1990,
Pubmed
Chiappinelli,
Kappa-neurotoxins: heterodimer formation between different neuronal nicotinic receptor antagonists.
1989,
Pubmed
Chiappinelli,
kappa-Bungarotoxin. Self-association of a neuronal nicotinic receptor probe.
1985,
Pubmed
Colquhoun,
Pharmacology of neuronal nicotinic acetylcholine receptor subtypes.
1997,
Pubmed
Coulson,
Insulin regulates neuronal M2 muscarinic receptor function in the ileum of diabetic rats.
2004,
Pubmed
Daltry,
Diet and snake venom evolution.
1996,
Pubmed
Dellisanti,
Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution.
2007,
Pubmed
Dewan,
Crystal structure of kappa-bungarotoxin at 2.3-A resolution.
1994,
Pubmed
de Weille,
Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel.
1991,
Pubmed
Emsley,
Coot: model-building tools for molecular graphics.
2004,
Pubmed
Fiordalisi,
Site-directed mutagenesis of kappa-bungarotoxin: implications for neuronal receptor specificity.
1994,
Pubmed
Fruchart-Gaillard,
Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor.
2002,
Pubmed
Gille,
STRAP: editor for STRuctural Alignments of Proteins.
2001,
Pubmed
GINSBORG,
The isolated chick biventer cervicis nerve-muscle preparation.
1960,
Pubmed
Gouet,
ESPript: analysis of multiple sequence alignments in PostScript.
1999,
Pubmed
Grant,
kappa-Bungarotoxin: complete amino acid sequence of a neuronal nicotinic receptor probe.
1985,
Pubmed
Grant,
Differential roles for disulfide bonds in the structural integrity and biological activity of kappa-Bungarotoxin, a neuronal nicotinic acetylcholine receptor antagonist.
1998,
Pubmed
,
Xenbase
Grant,
Critical interactions at the dimer interface of kappa-bungarotoxin, a neuronal nicotinic acetylcholine receptor antagonist.
1997,
Pubmed
Grutter,
Nicotinic receptors in wonderland.
2001,
Pubmed
Harvey,
Effects of muscarinic toxins MT1 and MT2 from green mamba on different muscarinic cholinoceptors.
2002,
Pubmed
Harvey,
Toxins 'R' Us: more pharmacological tools from nature's superstore.
2002,
Pubmed
Herz,
Distance between the agonist and noncompetitive inhibitor sites on the nicotinic acetylcholine receptor.
1989,
Pubmed
Hogg,
An automated system for intracellular and intranuclear injection.
2008,
Pubmed
,
Xenbase
Jiang,
Isolation and pharmacological characterization of a new alpha-neurotoxin (alpha-AgTx) from venom of the viper Agkistrodon halys (Pallas).
1987,
Pubmed
KATZ,
A study of the desensitization produced by acetylcholine at the motor end-plate.
1957,
Pubmed
Kini,
Molecular moulds with multiple missions: functional sites in three-finger toxins.
2002,
Pubmed
Krissinel,
Inference of macromolecular assemblies from crystalline state.
2007,
Pubmed
Kumar,
Snake venom cardiotoxins-structure, dynamics, function and folding.
1997,
Pubmed
Kuruppu,
Isolation and pharmacological characterisation of papuantoxin-1, a postsynaptic neurotoxin from the venom of the Papuan black snake (Pseudechis papuanus).
2005,
Pubmed
Langley,
On the contraction of muscle, chiefly in relation to the presence of "receptive" substances: Part I.
1907,
Pubmed
Laothong,
Decreased parasympathetic activities in Malayan krait (Bungarus candidus) envenoming.
2001,
Pubmed
Lewis,
Therapeutic potential of venom peptides.
2003,
Pubmed
Lumsden,
Pharmacological characterisation of a neurotoxin from the venom of Boiga dendrophila (mangrove catsnake).
2005,
Pubmed
Mackessy,
Venom of the Brown Treesnake, Boiga irregularis: ontogenetic shifts and taxa-specific toxicity.
2006,
Pubmed
McDowell,
Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins.
1992,
Pubmed
Ménez,
Refolding of reduced short neurotoxins: circular dichroism analysis.
1980,
Pubmed
Nirthanan,
Three-finger alpha-neurotoxins and the nicotinic acetylcholine receptor, forty years on.
2004,
Pubmed
Nirthanan,
Neuromuscular effects of candoxin, a novel toxin from the venom of the Malayan krait (Bungarus candidus).
2003,
Pubmed
Nirthanan,
Candoxin, a novel toxin from Bungarus candidus, is a reversible antagonist of muscle (alphabetagammadelta ) but a poorly reversible antagonist of neuronal alpha 7 nicotinic acetylcholine receptors.
2002,
Pubmed
Ohno,
Molecular evolution of snake toxins: is the functional diversity of snake toxins associated with a mechanism of accelerated evolution?
1998,
Pubmed
Olianas,
Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
1999,
Pubmed
Osipov,
Naturally occurring disulfide-bound dimers of three-fingered toxins: a paradigm for biological activity diversification.
2008,
Pubmed
,
Xenbase
Oswald,
Solution structure of neuronal bungarotoxin determined by two-dimensional NMR spectroscopy: sequence-specific assignments, secondary structure, and dimer formation.
1991,
Pubmed
Otwinowski,
Processing of X-ray diffraction data collected in oscillation mode.
1997,
Pubmed
Pahari,
The venom gland transcriptome of the Desert Massasauga rattlesnake (Sistrurus catenatus edwardsii): towards an understanding of venom composition among advanced snakes (Superfamily Colubroidea).
2007,
Pubmed
Pahari,
Expression pattern of three-finger toxin and phospholipase A2 genes in the venom glands of two sea snakes, Lapemis curtus and Acalyptophis peronii: comparison of evolution of these toxins in land snakes, sea kraits and sea snakes.
2007,
Pubmed
Palma,
Neuronal nicotinic alpha 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine.
1996,
Pubmed
,
Xenbase
Pawlak,
Denmotoxin, a three-finger toxin from the colubrid snake Boiga dendrophila (Mangrove Catsnake) with bird-specific activity.
2006,
Pubmed
Pawlak,
Irditoxin, a novel covalently linked heterodimeric three-finger toxin with high taxon-specific neurotoxicity.
2009,
Pubmed
Perrakis,
Automated protein model building combined with iterative structure refinement.
1999,
Pubmed
Pung,
Ohanin, a novel protein from king cobra venom, induces hypolocomotion and hyperalgesia in mice.
2005,
Pubmed
Rajagopalan,
Beta-cardiotoxin: a new three-finger toxin from Ophiophagus hannah (king cobra) venom with beta-blocker activity.
2007,
Pubmed
Ricciardi,
Do structural deviations between toxins adopting the same fold reflect functional differences?
2000,
Pubmed
Servent,
Molecular characterization of the specificity of interactions of various neurotoxins on two distinct nicotinic acetylcholine receptors.
2000,
Pubmed
Servent,
Muscarinic toxins: tools for the study of the pharmacological and functional properties of muscarinic receptors.
2009,
Pubmed
Servent,
How do snake curaremimetic toxins discriminate between nicotinic acetylcholine receptor subtypes.
1998,
Pubmed
Starkov,
[New weak toxins from the cobra venom].
2009,
Pubmed
Staros,
N-hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers.
1982,
Pubmed
Tan,
Isolation and pharmacological characterisation of hostoxin-1, a postsynaptic neurotoxin from the venom of the Stephen's banded snake (Hoplocephalus stephensi).
2006,
Pubmed
Teixeira-Clerc,
How do short neurotoxins bind to a muscular-type nicotinic acetylcholine receptor?
2002,
Pubmed
Torres,
NMR structure of bucandin, a neurotoxin from the venom of the Malayan krait (Bungarus candidus).
2001,
Pubmed
Trémeau,
Genetic engineering of snake toxins. The functional site of Erabutoxin a, as delineated by site-directed mutagenesis, includes variant residues.
1995,
Pubmed
Tsetlin,
Snake venom alpha-neurotoxins and other 'three-finger' proteins.
1999,
Pubmed
Unwin,
Nicotinic acetylcholine receptor at 9 A resolution.
1993,
Pubmed
Vagin,
REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use.
2004,
Pubmed
Warrell,
Severe neurotoxic envenoming by the Malayan krait Bungarus candidus (Linnaeus): response to antivenom and anticholinesterase.
1983,
Pubmed
Weiser,
Characterization of postjunctional muscarinic receptors mediating contraction in rat anococcygeus muscle.
1997,
Pubmed
Wolf,
kappa-Bungarotoxin: binding of a neuronal nicotinic receptor antagonist to chick optic lobe and skeletal muscle.
1988,
Pubmed
